Literature DB >> 12807956

Chapter 18: Statistical issues in the design and analysis of studies of human papillomavirus and cervical neoplasia.

Sholom Wacholder1.   

Abstract

Appropriately sophisticated statistical approaches are crucial for addressing the increasingly complex set of critical questions that follow from the recognition that human papillomavirus (HPV) is a necessary causal factor for cervical cancer. Cervical cancer researchers have defined the major stages of cervical carcinogenesis, with HPV infection as the necessary cause. Focus of etiologic studies is shifting from establishing causality to determining risk factors for HPV persistence and neoplastic progression using serially collected biomarkers. Prevention-oriented epidemiology and trials of new screening strategies and vaccines will rely on surrogate endpoints because we cannot let women develop cancer when it can be prevented. Future epidemiologic and prevention studies of HPV infection and cervical carcinogenesis will exploit subtle pathologic distinctions and will employ improved measurements of complex molecular biologic phenomena. The anticipated statistical issues are highlighted in this discussion.

Entities:  

Mesh:

Year:  2003        PMID: 12807956     DOI: 10.1093/oxfordjournals.jncimonographs.a003474

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  7 in total

1.  Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.

Authors:  Mahboobeh Safaeian; Koen Quint; Mark Schiffman; Ana Cecilia Rodriguez; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Raphael P Viscidi; Wim Quint; Robert D Burk
Journal:  J Natl Cancer Inst       Date:  2010-11-23       Impact factor: 13.506

2.  Tumor-based case-control studies of infection and cancer: muddling the when and where of molecular epidemiology.

Authors:  Eric A Engels; Sholom Wacholder; Hormuzd A Katki; Anil K Chaturvedi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-25       Impact factor: 4.254

3.  Precursors in cancer epidemiology: aligning definition and function.

Authors:  Sholom Wacholder
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

4.  Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy.

Authors:  M Kang; S Cu-Uvin
Journal:  HIV Med       Date:  2012-01-19       Impact factor: 3.180

5.  Age of diagnosis of squamous cell cervical carcinoma and early sexual experience.

Authors:  Zoe R Edelstein; Margaret M Madeleine; James P Hughes; Lisa G Johnson; Stephen M Schwartz; Denise A Galloway; Joseph J Carter; Laura A Koutsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-24       Impact factor: 4.254

6.  The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women.

Authors:  Vandana A Govan; Debbie Constant; Margaret Hoffman; Anna-Lise Williamson
Journal:  BMC Cancer       Date:  2006-01-26       Impact factor: 4.430

7.  Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma.

Authors:  Mahboobeh Safaeian; Lisa G Johnson; Kai Yu; Sophia S Wang; Patti E Gravitt; John A Hansen; Mary Carrington; Stephen M Schwartz; Xiaojiang Gao; Allan Hildesheim; Margaret M Madeleine
Journal:  Front Oncol       Date:  2014-06-19       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.